(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17 -oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacy clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside
Q6DC22 — Glycine receptor beta subunit 2
ECOD Domain Annotations
ECOD domains from AlphaFold model interacting with ligand IVM
| UniProt | DrugBank | PDB Ligand | Domain Label | ECOD ID | X Group | H Group | T Group | F Group |
|---|---|---|---|---|---|---|---|---|
| No predicted ECOD data found | ||||||||
ECOD domains from experimental PDB structures interacting with ligand IVM
| UniProt | DrugBank | PDB ID | Ligand Acc. | Chain | Res No. | Exp. Domain | X Group | H Group | T Group | F Group |
|---|---|---|---|---|---|---|---|---|---|---|
| Q6DC22 | n/a | 8fe1 | IVM | D | 502 | e8fe1E1 | Neurotransmitter-gated ion-channel transmembrane pore | Neurotransmitter-gated ion-channel transmembrane pore | Neurotransmitter-gated ion-channel transmembrane pore | Neur_chan_memb |
| Q6DC22 | n/a | 8fe1 | IVM | D | 502 | e8fe1E2 | Immunoglobulin-like beta-sandwich | Nicotinic receptor ligand binding domain-like | Nicotinic receptor ligand binding domain-like | Neur_chan_LBD |